Superworth

Tvardi Therapeutics profit margin TVRD

Gross, operating and net profit as a share of revenue over the last twelve months, from 2013.

Net margin, 12 months
n/m
a quarter missing
Peer median
9.2%

Tvardi Therapeutics' net margin over the last twelve months can't be worked out yet: a quarter of its results is missing from our data.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025n/an/an/a
FY2024n/an/a91.3%
FY2023n/an/a70.6%
FY2022n/an/a82.6%
FY2021n/an/an/a
FY20206.2%4.0%n/a
FY2019n/an/an/a
FY2018n/an/an/a
FY2017n/an/an/a
FY2016n/an/an/a
FY2015n/an/an/a
FY2014n/an/an/a
FY2013−33.1%−2.0%n/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a year
Q2 FY26n/an/a
Q1 FY26n/an/a
Q4 FY25n/an/a
Q3 FY25n/an/a
Q2 FY25n/an/a
Q1 FY25n/an/a
Q4 FY24n/an/a
Q3 FY24n/an/a
Q2 FY24n/an/a
Q1 FY24n/an/a
Q4 FY23n/an/a
Q3 FY23n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Tvardi Therapeutics' size, closest first, today.

CompanyProfit margin
TVRDTvardi Therapeuticsn/m
ATNMActinium Pharmaceuticalsn/m
SPROSpero Therapeutics15.7%
LFVNLifevantage2.8%
Peer median9.2%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Tvardi Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.